Before you sell to, join or invest in Somnum Pharma, Inc.
MentionFox check on Somnum Pharma, Inc.: only 1 source on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/somnum-pharma-inc-form-d-24000001
Check Somnum Pharma, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Somnum Pharma, Inc. filed a Form D with the Securities and Exchange Commission on 2024-11-29.
Somnum Pharma, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 29, 2024. The filing reports $2M sold. Its industry group is Pharmaceuticals. It names Orrin Devinsky (Director), Michael Jasulavic (Director) (SEC Form D, November 29, 2024).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Somnum Pharma, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-11-29 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Somnum Pharma, Inc.
Free to see. No signup.
Get an email when Somnum Pharma, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Somnum Pharma, Inc. raises, hires or launches. No email unless you switch it on.
Watch Somnum Pharma, Inc. →Get the full cited report on Somnum Pharma, Inc.
What the filing shows about Somnum Pharma, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Somnum Pharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Somnum Pharma, Inc.'s address as 4 East 70TH Street, 9A, New York, NY 10021.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Somnum Pharma, Inc. is a registered filer with the SEC (CIK 2046710) and has filed since 2024-11-29. 1 filing is on record, the latest on 2024-11-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Somnum Pharma, Inc.'s Form D of 2024-11-29 names Orrin Devinsky and Michael Jasulavic as its officers, directors or promoters.
Its new offerings report $2M sold across 1 offering, as its own filings state.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Orrin Devinsky is named as Director on the Form D that Somnum Pharma, Inc. filed with the SEC on 29 November 2024, one of 2 people that filing names.
Michael Jasulavic is named as Director on the Form D that Somnum Pharma, Inc. filed with the SEC on 29 November 2024, one of 2 people that filing names.
2 people named on the filing — 2 as directors only.
Named as of the 2024-11-29 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Somnum Pharma, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Somnum Pharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Somnum Pharma, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Somnum Pharma, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Somnum Pharma, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Somnum Pharma, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/somnum-pharma-inc-form-d-24000001